Clinical In-use Observational Trial to Evaluate the Updated Inserter for the Travoprost Intracameral Implant 75 mcg
Status: Recruiting
Location: See location...
Intervention Type: Combination product
Study Type: Observational
SUMMARY
Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Diagnosis of Open-angle glaucoma
• 18 years of age or older
Locations
United States
Wisconsin
Glaukos Investigative Site
RECRUITING
Kenosha
Contact Information
Primary
Study Director
ClinicalResearch@glaukos.com
949-739-8749
Time Frame
Start Date: 2025-12-17
Estimated Completion Date: 2026-07
Participants
Target number of participants: 30
Treatments
Model G2-TRIO
Subjects receive a Travoprost intracameral implant with the Model G2-TRIO
Related Therapeutic Areas
Sponsors
Leads: Glaukos Corporation